These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12524963)

  • 1. [Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis].
    Egorov VI; Kozarenko AV
    Vestn Otorinolaringol; 2002; (5):35-6. PubMed ID: 12524963
    [No Abstract]   [Full Text] [Related]  

  • 2. [Avelox efficacy in the treatment of acute purulent rhinosinusitis].
    Ivanchenko OA; Chuchueva NG; Lopatin AS
    Ter Arkh; 2007; 79(8):41-4. PubMed ID: 17926470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin.
    Johnson P; Adelglass J; Rankin B; Sterling R; Keating K; Benson A; Pertel P
    Int J Clin Pract; 2008 Sep; 62(9):1366-72. PubMed ID: 18671753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
    Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA;
    J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of the drug tavanik (levofloxacin) in acute and maxillary sinusitis].
    Kriukov AI; Sedinkin AA; Gerasimov KV
    Vestn Otorinolaringol; 2003; (1):30-1. PubMed ID: 12666597
    [No Abstract]   [Full Text] [Related]  

  • 6. Avelox. Respiratory antibiotic now in i.v. form.
    Nursing; 2002 Mar; 32(3):26. PubMed ID: 11902040
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of laser therapy in inflammatory diseases of the paranasal sinuses].
    Elistratov VV; Naumov GP; Naumov OG; Fishkin VA
    Vestn Otorinolaringol; 1996; (4):46-7. PubMed ID: 8966880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study.
    Zhou B; Jiang X; Zhai L; Xiao S; Wang J; Xiao G; Ruan B; Liang C; Ye Q; Hu B; Wang H
    Acta Otolaryngol; 2010 Sep; 130(9):1058-64. PubMed ID: 20235900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.
    Burke T; Villanueva C; Mariano H; Huck W; Orchard D; Haverstock D; Heyd A; Church D
    Clin Ther; 1999 Oct; 21(10):1664-77. PubMed ID: 10566563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxifloxacin (Avelox) for the treatment of bacterial skin infections.
    Parish LC; Witkowski JA; Routh HB
    Skin Therapy Lett; 2001 Oct; 6(11):1-2. PubMed ID: 11719825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
    El'kun GB
    Vestn Otorinolaringol; 1999; (6):45-6. PubMed ID: 10596605
    [No Abstract]   [Full Text] [Related]  

  • 12. [Moxifloxacin: results of clinical use].
    Iakovlev VP; Polushkina NR
    Antibiot Khimioter; 2002; 47(10):32-6. PubMed ID: 12674792
    [No Abstract]   [Full Text] [Related]  

  • 13. An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients.
    Jareoncharsri P; Bunnag C; Fooanant S; Tunsuriyawong P; Voraprayoon S; Srifuengfung S; Dhiraputra C
    Rhinology; 2004 Mar; 42(1):23-9. PubMed ID: 15072030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxifloxacin--a new fluoroquinolone antibacterial.
    Drug Ther Bull; 2004 Aug; 42(8):61-2. PubMed ID: 15310155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxifloxacin in the treatment of acute maxillary sinusitis after first-line treatment failure and acute sinusitis with high risk of complications.
    Gehanno P; Berche P; Perrin A
    J Int Med Res; 2003; 31(5):434-47. PubMed ID: 14587313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of using bioparox in the treatment of patients with diseases of the upper airways].
    Ovchinnikov IuM; Svishtushkin VM; Nikiforova GN; Iarin IuM; Morozova OA
    Vestn Otorinolaringol; 1996; (3):56-7. PubMed ID: 8928384
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nongonococcal urethritis treatment in men with avelox (moxifloxacin)].
    Aboian IA; Pavlov SV; Miroshnichenko VI; Shestel' AN
    Urologiia; 2007; (1):49-52. PubMed ID: 17472000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving care for patients with respiratory tract infections.
    Lode H; Garau J
    J Chemother; 2002 Feb; 14 Suppl 2():22-8. PubMed ID: 12003137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus.
    He L; Ta CN; Miño de Kaspar H
    J Cataract Refract Surg; 2009 Oct; 35(10):1715-8. PubMed ID: 19781465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.